Free Trial

9 Meters Biopharma (NMTR) Short Interest Ratio & Short Volume

9 Meters Biopharma logo

9 Meters Biopharma Short Interest Data

9 Meters Biopharma (NMTR) has a short interest of 580,600 shares, representing 4.08% of the float (the number of shares available for trading by the public). This marks a -1.02% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.4, indicating that it would take 1.4 days of the average trading volume of 315,915 shares to cover all short positions.

Current Short Interest
580,600 shares
Previous Short Interest
586,600 shares
Change Vs. Previous Month
-1.02%
Dollar Volume Sold Short
$391,905.00
Short Interest Ratio
1.4 Days to Cover
Last Record Date
July 15, 2023
Outstanding Shares
14,336,000 shares
Float Size
14,220,000 shares
Short Percent of Float
4.08%
Today's Trading Volume
40 shares
Average Trading Volume
315,915 shares
Today's Volume Vs. Average
0%
Short Selling 9 Meters Biopharma?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for 9 Meters Biopharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

NMTR Short Interest Over Time

NMTR Days to Cover Over Time

NMTR Percentage of Float Shorted Over Time

9 Meters Biopharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/2023580,600 shares $391,905.00 -1.0%4.1%1.4 $0.68
6/30/2023586,600 shares $394,195.20 +1.3%4.1%7.8 $0.67
6/15/2023579,000 shares $408,252.90 -1.8%4.1%7.5 $0.71
5/31/2023589,400 shares $412,580.00 +12.7%4.2%6.9 $0.70
5/15/2023523,200 shares $377,750.40 +8.2%3.7%6.6 $0.72
4/30/2023483,400 shares $420,558.00 +1.6%3.4%6.4 $0.87
4/15/2023475,800 shares $639,951.00 -0.5%3.4%7.9 $1.35
3/31/2023478,100 shares $664,559.00 -2.1%3.4%7 $1.39
3/15/2023488,500 shares $683,900.00 +22.0%3.5%4.5 $1.40
2/28/2023400,300 shares $680,510.00 -7.3%3.1%3.6 $1.70
2/15/2023431,600 shares $953,836.00 -15.7%3.4%3.8 $2.21
1/31/2023512,200 shares $1.03 million +17.3%7.1%4.4 $2.02
1/15/2023436,700 shares $1.02 million +14.8%3.4%3.6 $2.33
12/30/2022380,400 shares $479,304.00 -3.9%3.0%2.9 $1.26
12/15/2022395,800 shares $494,750.00 +41.5%3.1%3.4 $1.25
11/30/2022279,800 shares $478,458.00 +41.8%2.2%2.6 $1.71
11/15/2022197,300 shares $444,911.50 +22.4%1.5%2 $2.26
10/31/2022161,200 shares $414,284.00 +30.5%1.3%1.6 $2.57
10/15/2022123,500 shares $512,278.00 -97.0%1.0%1.1 $4.15
9/30/20224,130,000 shares $887,950.00 +65.9%N/A1.9 $0.22
9/15/20222,490,000 shares $574,194.00 +16.4%N/A0.8 $0.23
8/31/20222,140,000 shares $567,314.00 +13.8%N/A0.5 $0.27
8/15/20221,880,000 shares $545,200.00 -42.0%0.8%0.4 $0.29
7/31/20223,240,000 shares $713,124.00 -37.0%1.3%0.8 $0.22
7/15/20225,140,000 shares $1.25 million -36.2%2.1%1.3 $0.24
6/30/20228,060,000 shares $2.10 million -51.0%3.2%2.1 $0.26
6/15/202216,460,000 shares $9.51 million +7.2%6.9%6.2 $0.58
5/31/202215,350,000 shares $6.94 million +7.4%6.5%11.5 $0.45
5/15/202214,290,000 shares $5.38 million +3.1%6.0%10.6 $0.38
4/30/202213,860,000 shares $5.79 million +10.6%5.9%10.5 $0.42
4/15/202212,530,000 shares $6.79 million +12.7%5.3%9.1 $0.54
3/31/202211,120,000 shares $6.66 million +11.8%4.7%8.3 $0.60
3/15/20229,950,000 shares $5.19 million +6.4%4.3%6.9 $0.52
2/28/20229,350,000 shares $5.11 million +5.2%4.0%6 $0.55
2/15/20228,890,000 shares $6.18 million +6.2%3.8%5.7 $0.70
1/31/20228,370,000 shares $6.39 million +2.7%3.5%5.3 $0.76
1/15/20228,150,000 shares $6.96 million +11.6%3.5%5 $0.85
12/31/20217,300,000 shares $7.15 million +12.0%3.1%4.4 $0.98
12/15/20216,520,000 shares $5.67 million +0.2%2.8%3.7 $0.87
11/30/20216,510,000 shares $6.77 million -7.0%2.8%3.6 $1.04
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)

Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?

Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.
11/15/20217,000,000 shares $7.91 million -16.2%3.0%3.7 $1.13
10/29/20218,350,000 shares $10.60 million -2.6%3.6%4.3 $1.27
10/15/20218,570,000 shares $11.06 million +1.3%3.7%4.3 $1.29
9/30/20218,460,000 shares $11.00 million -4.0%3.6%3.4 $1.30
9/15/20218,810,000 shares $11.01 million +6.4%3.8%2.1 $1.25
8/31/20218,280,000 shares $10.76 million +21.9%3.5%1.9 $1.30
8/13/20216,790,000 shares $7.06 million -2.6%2.9%1.5 $1.04
7/30/20216,970,000 shares $7.53 million -24.2%3.0%1.5 $1.08
7/15/20219,190,000 shares $10.02 million -0.4%3.8%1.8 $1.09
6/30/20219,230,000 shares $10.15 million +0.1%3.9%1.9 $1.10
6/15/20219,220,000 shares $13.28 million +1.7%3.9%2.1 $1.44
5/28/20219,070,000 shares $11.61 million +3.0%3.8%2 $1.28
5/14/20218,810,000 shares $9.25 million +89.1%3.7%1.9 $1.05
4/30/20214,660,000 shares $5.64 million +5.9%2.0%0.8 $1.21
4/15/20214,400,000 shares $5.15 million +1.9%1.9%0.6 $1.17
3/31/20214,320,000 shares $5.88 million +16.4%1.8%0.5 $1.36
3/15/20213,710,000 shares $6.27 million +14.9%1.9%0.4 $1.69
2/26/20213,230,000 shares $5.38 million -11.3%1.7%0.3 $1.67
2/12/20213,640,000 shares $6.92 million -36.7%1.9%0.3 $1.90
1/29/20215,750,000 shares $6.15 million -6.4%3.1%0.6 $1.07
1/15/20216,140,000 shares $8.10 million No Change3.3%0.8 $1.32

NMTR Short Interest - Frequently Asked Questions

What is 9 Meters Biopharma's current short interest?

Short interest is the volume of 9 Meters Biopharma shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 580,600 shares of NMTR short. 4.08% of 9 Meters Biopharma's shares are currently sold short. Learn More on 9 Meters Biopharma's current short interest.

What is a good short interest ratio for 9 Meters Biopharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NMTR shares currently have a short interest ratio of 1.0. Learn More on 9 Meters Biopharma's short interest ratio.

What is a good short interest percentage for 9 Meters Biopharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.08% of 9 Meters Biopharma's floating shares are currently sold short.

Is 9 Meters Biopharma's short interest increasing or decreasing?

9 Meters Biopharma saw a drop in short interest in July. As of July 15th, there was short interest totaling 580,600 shares, a drop of 1.0% from the previous total of 586,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is 9 Meters Biopharma's float size?

9 Meters Biopharma currently has issued a total of 14,336,000 shares. Some of 9 Meters Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. 9 Meters Biopharma currently has a public float of 14,220,000 shares.

How does 9 Meters Biopharma's short interest compare to its competitors?

4.08% of 9 Meters Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to 9 Meters Biopharma: Galecto, Inc. (5.05%), Lixte Biotechnology Holdings, Inc. (1.42%), Sonnet BioTherapeutics Holdings, Inc. (5.43%), IM Cannabis Corp. (0.64%), Pasithea Therapeutics Corp. (19.04%), Windtree Therapeutics, Inc. (8.89%), RedHill Biopharma Ltd. (2.09%), Sunshine Biopharma, Inc. (3.78%), Mustang Bio, Inc. (3.10%), InMed Pharmaceuticals Inc. (6.12%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($3.75 billion), Charter Communications, Inc. ($3.17 billion), Occidental Petroleum Co. ($2.86 billion), Rivian Automotive, Inc. ($2.29 billion), T. Rowe Price Group, Inc. ($2.13 billion), Royal Caribbean Cruises Ltd. ($2.05 billion), Palantir Technologies Inc. ($2.04 billion), Extra Space Storage Inc. ($1.98 billion), Enphase Energy, Inc. ($1.66 billion), and Tractor Supply ($1.61 billion). View all of the most shorted stocks.

What does it mean to sell short 9 Meters Biopharma stock?

Short selling NMTR is an investing strategy that aims to generate trading profit from 9 Meters Biopharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against 9 Meters Biopharma?

A short squeeze for 9 Meters Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NMTR, which in turn drives the price of the stock up even further.

How often is 9 Meters Biopharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NMTR, twice per month. The most recent reporting period available is July, 15 2023.




This page (NASDAQ:NMTR) was last updated on 5/10/2025 by MarketBeat.com Staff
From Our Partners